Volume | 498,914 |
|
|||||
News | - | ||||||
Day High | 21.21 | Low High |
|||||
Day Low | 20.35 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Cassava Sciences Inc | SAVA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
20.65 | 20.35 | 21.21 | 20.55 | 20.50 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
8,715 | 498,914 | $ 20.77 | $ 10,360,902 | - | 12.3202 - 32.10 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:10:17 | 25 | $ 20.64 | USD |
Cassava Sciences (SAVA) Options Flow Summary
Cassava Sciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
16.43M | 43.23M | - | 0 | -97.22M | -2.25 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Cassava Sciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SAVA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 19.97 | 21.94 | 19.435 | 20.64 | 986,837 | 0.69 | 3.46% |
1 Month | 19.89 | 26.6757 | 19.435 | 22.11 | 1,004,141 | 0.77 | 3.87% |
3 Months | 24.92 | 26.6757 | 18.18 | 22.02 | 743,192 | -4.26 | -17.09% |
6 Months | 13.85 | 32.10 | 13.37 | 23.15 | 1,025,256 | 6.81 | 49.17% |
1 Year | 23.25 | 32.10 | 12.3202 | 21.75 | 985,850 | -2.59 | -11.14% |
3 Years | 37.11 | 146.16 | 12.3202 | 49.61 | 2,378,521 | -16.45 | -44.33% |
5 Years | 1.12 | 146.16 | 1.00 | 34.37 | 2,786,646 | 19.54 | 1,744.64% |
Cassava Sciences Description
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. |